Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

Fig. 2

Construction and characterization of DOX and PD-L1 siRNA encapsulated nanoparticles (NPDOX/siPD-L1). a The diagram of the construction of NPDOX/siPD-L1. b The weight ratios of DOTAP to siPD-L1 were determined using gel retardation. Besides, c, d TEM image, size distribution, and surface potential of NPDOX/siPD-L1 were also determined. All the experiments were repeated three times with similar results

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us